Open original FDA record ↗Recall record
- FDA identifier
- Z-0271-2023
- Company in FDA record
- Kamiya Biomedical Company, LLC
- FDA classification date
- Nov 21, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
IgA Reagent may start showing cloudiness over time, which can affect assay performance.
Source facts
- Action
- On 9/28/22, recall notices were sent to customers informing them to stop using affected kit lots and to return complete and partially used kits to the recalling firm. Further, if opaque turbidity is observed, or the controls of the affected assay are not within range, do not report the test results. Distributors are asked to contact their customers and to inform them of the recall. Alternately, distributors can send the recalling firm their customer list so the recalling firm can notify the customers directly. Complete and return the customer acknowledgement. The following firm contacts were provided: (206) 575-8068 and quality@k-assay.com
- Initiated
- 2022-09-28
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution in the states of FL, NC, TX, TN, PA, CA, NY, IL, MA and the country of Czech Republic.
- Recall number
- Z-0271-2023
- Recall status
- Open, Classified
- CDRH record ID
- 196551
- FDA classified
- 2022-11-21
- Recall event number
- 91030